Yale-NBA Partnership Results in FDA Approval for COVID-19 SalivaDirect Test
XTalks
AUGUST 18, 2020
An important feature of the test that contributes to its reduced cost is the fact that sample processing does not require a separate nucleic acid (RNA) extraction step. This is significant because shortages of RNA extraction kits have been a recurrent issue since the beginning of the pandemic.
Let's personalize your content